INCY Competitors
Incyte Corporation
$116.62
+$3.36(+2.97%)
58
Overall
80
Value
27
Tech
68
Quality
Market Cap
$22.96B
Volume
1.34M
52W Range
$84.02 - $132.60
Target Price
$129.72
INCY competitors: AMGN, LGND, LLY, PFE, GERN. Incyte Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
INCY Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $437.11 | $229.74B | $22.94 | 2.27% | 65 |
| LGND Ligand Pharmaceuticals Incorporated | $308.70 | $5.93B | $5.25 | - | 63 |
| LLY Eli Lilly and Company | $1283.66 | $1.17T | $33.56 | 0.52% | 66 |
| PFE Pfizer Inc. | $30.15 | $167.80B | $2.95 | 5.70% | 70 |
| GERN Geron Corporation | $1.23 | $770.97M | $-0.04 | - | 40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $116.62 | +3.0% | 1.34M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |